Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.21.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive income
Preferred stock
Accumulated deficit
Beginning Balance at Jun. 30, 2019 $ 1,968 $ 4 $ 57,543 $ 21 $ 4,978 $ (60,578)
Beginning Balance, shares at Jun. 30, 2019   3,839,000        
Issuance of shares and warrants - net of issue costs 6,583 $ 5 6,578      
Issuance of shares and warrants - net of issue costs, shares   4,895,000        
Exercise of pre-funded warrants for cash 26 $ 2 24      
Exercise of pre-funded warrants for cash, shares   2,655,000        
Exercise of warrants for cash 25   25      
Exercise of warrants for cash, shares   25,000        
Conversion of Series B preferred stock to common stock     174   (174)  
Conversion of Series B preferred stock to common stock, shares   6,000        
Shares issued for services 13   13      
Shares issued for services, shares   23,000        
Warrants issued for services 287   287      
Stock option expense 495   495      
Series A preferred cash dividend (8)         (8)
Series B preferred stock dividend     9     (9)
Series B preferred stock dividend, shares   15,000        
Loss for the year (9,126)         (9,126)
Ending Balance at Jun. 30, 2020 263 $ 11 65,148 21 4,804 (69,721)
Ending Balance, shares at Jun. 30, 2020   11,458,000        
Adgero merger (note 3) 16,725 $ 12 16,713      
Adgero merger, shares   12,011,000        
Issuance of Series C Preferred stock 25,028       25,028  
Series C placement agent warrants     3,287   (3,287)  
Series C Preferred stock share issuance costs (3,455)       (3,455)  
Deemed dividend recognized on beneficial conversion features of Series C Preferred stock issuance     3,181     (3,181)
Exercise of warrants for cash 4,404 $ 4 4,400      
Exercise of warrants for cash, shares   4,677,000        
Conversion of Series B preferred stock to common stock     4,525   (4,525)  
Conversion of Series B preferred stock to common stock, shares   162,000        
Conversion of Series C Preferred stock to common stock 3,713 $ 5 3,708   (3,713)  
Conversion of Series C preferred stock to common stock, shares   4,251,000        
Series C Agent Warrants exercised     (79)   79  
Shares issued for services 0          
Shares issued for services, shares   0        
Warrants issued for services 569   569      
Stock options exercised 77 $ 1 76      
Stock options exercised, Shares   170,000        
Stock option expense 5,276   5,276      
Series A preferred cash dividend (8)         (8)
Series B preferred stock dividend     17     (17)
Series B preferred stock dividend, shares   11,000        
Loss for the year (38,298)         (38,298)
Ending Balance at Jun. 30, 2021 $ 10,581 $ 33 $ 106,821 $ 21 $ 14,931 $ (111,225)
Ending Balance, shares at Jun. 30, 2021   32,740,000